A Critical Review of the Consensus Statement from the European Atherosclerosis Society Consensus Panel 2017

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Pharmacology

• Publication date

  2018-01-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000486374PMID 29353277
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dietary Lactobacillus acidophilus and Mannan-Oligosaccharides Alter the Lipid Metabolism and Health Indices in Broiler Chickens

  2020cited by this paper
• Molecular mechanisms of signaling via the docosanoid neuroprotectin D1 for cellular homeostasis and neuroprotection

  2017cited by this paper
• Lipid-lowering drugs and risk of new-onset diabetes: a cohort study using Japanese healthcare data linked to clinical data for health screening

  2017cited by this paper
• Comment on ‘Statin use and all-cancer survival: prospective results from the Women's Health Initiative'

  2017cited by this paper
• Statins Cause Lifestyle-Related Diseases-Biochemical Mechanism

  2017cited by this paper
• Hospital Admissions for Myocardial Infarction and Stroke Before and After the Trans-Fatty Acid Restrictions in New York

  2017cited by this paper
• Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

  2017cited by this paper
• Saturated Fats and CVD : AHA Convicts , We Say Acquit

  2017cited by this paper
• Recent flaws in Evidence Based Medicine: statin effects in primary prevention and consequences of suspending the treatment.

  2017cited by this paper
• Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

  2017cited by this paper
• Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease

  2016cited by this paper
• Medicines and Vegetable Oils as Hidden Causes of Cardiovascular Disease and Diabetes

  2016cited by this paper
• Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.

  2016cited by this paper
• Impact of Nonoptimal Intakes of Saturated, Polyunsaturated, and Trans Fat on Global Burdens of Coronary Heart Disease

  2016cited by this paper
• Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review

  2016cited by this paper
• Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73)

  2016cited by this paper
• Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease.

  2016cited by this paper
• Inhibition of Rab prenylation by statins induces cellular glycosphingolipid remodeling.

  2016cited by this paper
• Impact of Nonoptimal Intakes of Saturated, Polyunsaturated, and Trans Fat on Global Burdens of Coronary Heart Disease

  2016cited by this paper
• Comment on ‘Statin use and all-cancer survival: prospective results from the Women’s Health Initiative’

  2016cited by this paper
• Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.

  2015cited by this paper
• Risk of hypercholesterolemia for cardiovascular disease and the population attributable fraction in a 24-year Japanese cohort study.

  2015cited by this paper
• Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies

  2015cited by this paper
• Title Page / Table of Contents / Preface

  2015cited by this paper
• Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial.

  2015cited by this paper
• PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial.

  2015cited by this paper
• Balancing proportions of competing omega-3 and omega-6 highly unsaturated fatty acids (HUFA) in tissue lipids.

  2015cited by this paper
• Vaccenic acid and trans fatty acid isomers from partially hydrogenated oil both adversely affect LDL cholesterol: a double-blind, randomized controlled trial.

  2015cited by this paper
• Different Fatty Acids Compete with Arachidonic Acid for Binding to the Allosteric or Catalytic Subunits of Cyclooxygenases to Regulate Prostanoid Synthesis*

  2015cited by this paper
• Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.

  2015cited by this paper
• Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients.

  2015cited by this paper
• Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort

  2015cited by this paper
• Evidence from randomised controlled trials did not support the introduction of dietary fat guidelines in 1977 and 1983: a systematic review and meta-analysis

  2015cited by this paper
• Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms

  2015cited by this paper
• Statin treatment and new-onset diabetes: a review of proposed mechanisms.

  2014cited by this paper
• Proprotein convertase subtilisin/kexin type 9 (PCSK9): lessons learned from patients with hypercholesterolemia.

  2014cited by this paper
• A coronary heart disease prediction model: the Korean Heart Study

  2014cited by this paper
• Canola and hydrogenated soybean oils accelerate ectopic bone formation induced by implantation of bone morphogenetic protein in mice

  2014cited by this paper
• What are lipoproteins doing in the brain?

  2014cited by this paper
• Dietary fatty acids in the secondary prevention of coronary heart disease: a systematic review, meta-analysis and meta-regression

  2014cited by this paper
• Omega-3 Fatty Acids Protect Renal Functions by Increasing Docosahexaenoic Acid-Derived Metabolite Levels in SHR.Cg-Leprcp/NDmcr Rats, a Metabolic Syndrome Model

  2014cited by this paper
• Statins inhibit insulin-like growth factor action in first trimester placenta by altering insulin-like growth factor 1 receptor glycosylation

  2014cited by this paper
• High cholesterol levels are associated with improved long-term survival after acute ischemic stroke.

  2014cited by this paper
• A 52-week placebo-controlled trial of evolocumab in hyperlipidemia.

  2014cited by this paper
• Old study sheds new light on the fatty acids and cardiovascular health debate

  2013cited by this paper
• Simvastatin impairs exercise training adaptations.

  2013cited by this paper
• Faculty Opinions recommendation of Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

  2013cited by this paper
• Association of Prestroke Statin Use and Lipid Levels With Outcome of Intracerebral Hemorrhage

  2013cited by this paper
• Maternal and offspring pools of osteocalcin influence brain development and functions.

  2013cited by this paper
• Omega-3 Fatty acids and hippocampal neurogenesis in depression.

  2013cited by this paper
• Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis

  2013cited by this paper
• Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance.

  2013cited by this paper
• Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 study.

  2012cited by this paper
• Cholesterol: Its Regulation and Role in Central Nervous System Disorders

  2012cited by this paper
• High serum total cholesterol levels is a risk factor of ischemic stroke for general Japanese population: the JPHC study.

  2012cited by this paper
• Cholesterol Issues in Japan – Why Are the Goals of Cholesterol Levels Set So Low

  2012cited by this paper
• Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative.

  2012cited by this paper
• Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 study

  2012cited by this paper
• Statins inhibit expression of thioredoxin reductase 1 in rat and human liver and reduce tumour development.

  2012cited by this paper
• Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

  2012cited by this paper
• Statins use and coronary artery plaque composition: results from the International Multicenter CONFIRM Registry.

  2012cited by this paper
• Sonic hedgehog regulates presynaptic terminal size, ultrastructure and function in hippocampal neurons

  2012cited by this paper
• Endocrine regulation of male fertility by the skeleton.

  2011cited by this paper
• Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor α system and interleukin-10.

  2011cited by this paper
• Comparison of risk factors for fatal stroke and ischemic heart disease: a prospective follow up of the health survey for England.

  2011cited by this paper
• Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)

  2011cited by this paper
• Low Cholesterol is Associated with Mortality from Cardiovascular Diseases: A Dynamic Cohort Study in Korean Adults

  2011cited by this paper
• Low serum cholesterol level and increased ischemic stroke mortality.

  2011cited by this paper
• No scientific support for linking dietary saturated fat to CHD

  2011cited by this paper
• New Cholesterol Guidelines for Longevity (2010).

  2011cited by this paper
• Vitamin K2 Supplementation Improves Insulin Sensitivity via Osteocalcin Metabolism: A Placebo-Controlled Trial

  2011cited by this paper
• Low Cholesterol is Associated With Mortality From Stroke, Heart Disease, and Cancer: The Jichi Medical School Cohort Study

  2010cited by this paper
• Myocardial fatty acid metabolism in health and disease.

  2010cited by this paper
• Dyslipidemia and Cardiovascular Disease: A Series of Epidemiologic Studies in Japanese Populations

  2010cited by this paper
• Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg).

  2010cited by this paper
• Dietary intake of saturated fatty acids and mortality from cardiovascular disease in Japanese: the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC) Study.

  2010cited by this paper
• Testosterone-lowering activity of canola and hydrogenated soybean oil in the stroke-prone spontaneously hypertensive rat.

  2010cited by this paper
• Hyperlipidemia effects on clinical indexes of stroke in Japanese patients

  2010cited by this paper
• Low-Density Lipoprotein Cholesterol Concentrations and Death Due to Intraparenchymal Hemorrhage: The Ibaraki Prefectural Health Study

  2009cited by this paper
• Arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and coronary heart disease risk in familial hypercholesterolemia.

  2009cited by this paper
• Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study.

  2009cited by this paper
• Different effects of 26-week dietary intake of rapeseed oil and soybean oil on plasma lipid levels, glucose-6-phosphate dehydrogenase activity and cyclooxygenase-2 expression in spontaneously hypertensive rats.

  2008cited by this paper
• A Transgenic Mouse Model for Gene–Nutrient Interactions

  2008cited by this paper
• Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study.

  2008cited by this paper
• Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

  2008cited by this paper
• Effects of torcetrapib in patients at high risk for coronary events

  2008cited by this paper
• Dihydrophylloquinone intake is associated with low bone mineral density in men and women.

  2007cited by this paper
• Serum total cholesterol levels and risk of mortality from stroke and coronary heart disease in Japanese: the JACC study.

  2007cited by this paper
• Prevention of coronary heart disease : from the cholesterol hypothesis to ω6/ω3 balance

  2007cited by this paper
• Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

  2007cited by this paper
• Effects of torcetrapib in patients at high risk for coronary events.

  2007cited by this paper
• The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort.

  2007cited by this paper
• Dietary Lipids Impacts on Healthy Ageing

  2007cited by this paper
• Prevention of Coronary Heart Disease

  2007cited by this paper
• Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.

  2007cited by this paper
• Exploration for unknown substances in rapeseed oil that shorten survival time of stroke-prone spontaneously hypertensive rats. Effects of super critical gas extraction fractions.

  2006cited by this paper
• Chemokines in Children With Heterozygous Familiar Hypercholesterolemia: Selective Upregulation of RANTES

  2006cited by this paper
• The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids.

  2005cited by this paper
• Why Eve Is Not Adam: Prospective Follow-Up in 149,650 Women and Men of Cholesterol and Other Risk Factors Related to Cardiovascular and All-Cause Mortality

  2004cited by this paper
• Primary Cardiovascular Events and Serum Lipid Levels in Elderly Japanese with Hypercholesterolemia Undergoing 6‐Year Simvastatin Treatment: A Subanalysis of the Japan Lipid Intervention Trial

  2004cited by this paper

• Is Targeting LDL-C Levels Below 70 mg/dL Beneficial for Cardiovascular and Overall Health? A Critical Examination of the Evidence

  2025cites this paper
• Evolving Concepts of the SCORE System: Subtracting Cholesterol from Risk Estimation: A Way for a Healthy Longevity?

  2024influential citation
• Cholesterol, Atherosclerosis, Lipid-Lowering Therapy. Is It Completely Clear?

  2024cites this paper
• Association between the triglyceride to high-density lipoprotein cholesterol ratio and mortality in Chinese maintenance haemodialysis patients: a retrospective cohort study

  2024cites this paper
• Association Between Dietary Patterns and Cardiovascular Diseases: A Review.

  2024cites this paper
• The Great Cholesterol Quandary and Global Consciousness Awakening

  2023cites this paper
• SGLT-2i: Nanoparticular-Based Strategies, Solutions, and Clinical Applications in Opposition to Low Bioavailability

  2023influential citation
• Historical Review of the Use of Relative Risk Statistics in the Portrayal of the Purported Hazards of High LDL Cholesterol and the Benefits of Lipid-Lowering Therapy

  2023cites this paper
• Chronic Kidney Disease of Unknown Aetiolgy (CKDu)-the search for causes and the impact of its politicization

  2023cites this paper
• Cholesterol and its biological significance. Atherosclerosis. Statin therapy (Part 1)

  2022cites this paper
• Statin therapy is not warranted for a person with high LDL-cholesterol on a low-carbohydrate diet.

  2022cites this paper
• Piezo1 mediates endothelial atherogenic inflammatory responses via regulation of YAP/TAZ activation

  2021cites this paper
• The homeoviscous adaptation to dietary lipids (HADL) model explains controversies over saturated fat, cholesterol, and cardiovascular disease risk.

  2021cites this paper
• Dyslipidemia and rupture risk of intracranial aneurysms—a systematic review

  2021cites this paper
• Major Causes Associated with Clinical Trials Failure and Selective Strategies to Reduce these Consequences: A Review

  2021cites this paper
• Statins in primary prevention: is the enthusiasm justified?

  2020cites this paper
• Low carbohydrate diet: are concerns with saturated fat, lipids, and cardiovascular disease risk justified?

  2020cites this paper
• Application of nutrient essentiality criteria to dietary carbohydrates

  2020cites this paper
• Conceptualization of Heterogeneity of Chronic Diseases and Atherosclerosis as a Pathway to Precision Medicine: Endophenotype, Endotype, and Residual Cardiovascular Risk

  2020cites this paper
• Dietary Recommendations for Familial Hypercholesterolaemia: an Evidence-Free Zone

  2020cites this paper
• Non-High-Density Lipoprotein Cholesterol and Guidelines for Cholesterol Lowering in Recent History.

  2019cites this paper
• Statins: Rationale, Mode of Action, and Side Effects

  2019cites this paper
• Pterostilbene reduces endothelial cell injury in vascular arterial walls by regulating the Nrf2-mediated AMPK/STAT3 pathway in an atherosclerosis rat model

  2019cites this paper
• The effect of combined ezetimibe and statin therapy versus statin therapy alone on coronary plaque volume assessed by intravascular ultrasound: A systematic review and meta-analysis.

  2018cites this paper
• LDL-C Does Not Cause Cardiovascular Disease: a comprehensive review of current literature

  2018cites this paper
• El debate sobre la importancia del LDL colesterol y uso de estatinas

  2018cites this paper
• LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature

  2018cites this paper